243 related articles for article (PubMed ID: 29283294)
1. Evaluating the role of clinical pharmacists in pre-procedural anticoagulation management.
Kataruka A; Renner E; Barnes GD
Hosp Pract (1995); 2018 Feb; 46(1):16-21. PubMed ID: 29283294
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
[TBL] [Abstract][Full Text] [Related]
3. The duration of anticoagulation bridging therapy in clinical practice may significantly exceed that observed in clinical trials.
Deerhake JP; Merz JC; Cooper JV; Eagle KA; Fay WP
J Thromb Thrombolysis; 2007 Apr; 23(2):107-13. PubMed ID: 17221327
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of pharmacist-based compared to doctor-based anticoagulation management in Qatar.
Elewa H; Jalali F; Khudair N; Hassaballah N; Abdelsamad O; Mohammed S
J Eval Clin Pract; 2016 Jun; 22(3):433-8. PubMed ID: 26766552
[TBL] [Abstract][Full Text] [Related]
5. Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care.
Hall D; Buchanan J; Helms B; Eberts M; Mark S; Manolis C; Peele P; Docimo A
Pharmacotherapy; 2011 Jul; 31(7):686-94. PubMed ID: 21923456
[TBL] [Abstract][Full Text] [Related]
6. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
Poon IO; Lal L; Brown EN; Braun UK
J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of a pharmacist-managed anticoagulation service for breast cancer patients.
Jones KL; Barnett C; Gauthier M; Boster B; Espirito JL; Michaud LB
J Oncol Pharm Pract; 2012 Mar; 18(1):122-7. PubMed ID: 21364079
[TBL] [Abstract][Full Text] [Related]
8. Pharmacy-managed anticoagulation: assessment of in-hospital efficacy and evaluation of financial impact and community acceptance.
Donovan JL; Drake JA; Whittaker P; Tran MT
J Thromb Thrombolysis; 2006 Aug; 22(1):23-30. PubMed ID: 16786229
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic kidney disease on warfarin management in a pharmacist-managed anticoagulation clinic.
Kleinow ME; Garwood CL; Clemente JL; Whittaker P
J Manag Care Pharm; 2011 Sep; 17(7):523-30. PubMed ID: 21870893
[TBL] [Abstract][Full Text] [Related]
10. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial.
Verret L; Couturier J; Rozon A; Saudrais-Janecek S; St-Onge A; Nguyen A; Basmadjian A; Tremblay S; Brouillette D; de Denus S
Pharmacotherapy; 2012 Oct; 32(10):871-9. PubMed ID: 23033226
[TBL] [Abstract][Full Text] [Related]
11. Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy.
Spyropoulos AC; Frost FJ; Hurley JS; Roberts M
Chest; 2004 May; 125(5):1642-50. PubMed ID: 15136371
[TBL] [Abstract][Full Text] [Related]
12. Evaluating warfarin management by pharmacists in a community teaching hospital.
Chilipko AA; Norwood DK
Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419
[TBL] [Abstract][Full Text] [Related]
13. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
[TBL] [Abstract][Full Text] [Related]
14. Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service.
Dager WE; Branch JM; King JH; White RH; Quan RS; Musallam NA; Albertson TE
Ann Pharmacother; 2000 May; 34(5):567-72. PubMed ID: 10852081
[TBL] [Abstract][Full Text] [Related]
15. Comparing effectiveness of two anticoagulation management models in a Malaysian tertiary hospital.
Thanimalai S; Shafie AA; Hassali MA; Sinnadurai J
Int J Clin Pharm; 2013 Oct; 35(5):736-43. PubMed ID: 23715759
[TBL] [Abstract][Full Text] [Related]
16. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.
Garwood CL; Dumo P; Baringhaus SN; Laban KM
Pharmacotherapy; 2008 Jan; 28(1):20-6. PubMed ID: 18154470
[TBL] [Abstract][Full Text] [Related]
17. Impact of clinical pharmacist intervention in anticoagulation clinic in Sudan.
Ahmed NO; Osman B; Abdelhai YM; El-Hadiyah TMH
Int J Clin Pharm; 2017 Aug; 39(4):769-773. PubMed ID: 28508324
[TBL] [Abstract][Full Text] [Related]
18. Comparison of physician- and pharmacist-managed warfarin sodium treatment in open heart surgery patients.
Tschol N; Lai DK; Tilley JA; Wong H; Brown GR
Can J Cardiol; 2003 Nov; 19(12):1413-7. PubMed ID: 14631476
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two different models of anticoagulation management services with usual medical care.
Rudd KM; Dier JG
Pharmacotherapy; 2010 Apr; 30(4):330-8. PubMed ID: 20334453
[TBL] [Abstract][Full Text] [Related]
20. Assessment of oral anticoagulation control at two pharmacist-managed clinics in Brazil.
de Lima Silva RG; Bertollo CM; Ferreira IG; Brant LC; Martins MAP
Int J Clin Pharm; 2017 Dec; 39(6):1157-1161. PubMed ID: 28932938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
